Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00001 | 35259705 | Diabetes Metab Syndr | Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosis. | 2022 | Details |
| A00011 | 35255600 | Endocrinol Metab (Seoul) | State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis. | 2022 | Details |
| A00021 | 35251583 | J Healthc Eng | Preliminary Study on Risk Factors for Morbidity of Nonalcoholic Fatty Liver Disease in High-Income Male Population. | 2022 | Details |
| A00050 | 35243111 | Transl Gastroenterol Hepatol | Palm tocotrienol rich fraction with palm kernel oil supplementation prevents development of liver steatosis in high fat diet ICR mice. | 2022 | Details |
| A00057 | 35238939 | J Clin Endocrinol Metab | Long or Irregular Menstrual Cycles and Risk of Prevalent and Incident Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00077 | 35229329 | Hepatology | Risk Factors for Hepatocellular Cancer in Contemporary Cohorts of Patients with Cirrhosis. | 2022 | Details |
| A00086 | 35225189 | Br J Nutr | Organ meat consumption and risk of nonalcoholic fatty liver disease: the TCLSIH study. | 2022 | Details |
| A00097 | 35220673 | Liver Int | Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes. | 2022 | Details |
| A00102 | 35218767 | Life Sci | Hesperidin attenuates hepatic lipid accumulation in mice fed high-fat diet and oleic acid induced HepG2 via AMPK activation. | 2022 | Details |
| A00154 | 35207209 | J Clin Med | Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults. | 2022 | Details |
| A00168 | 35203457 | Biomedicines | Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences. | 2022 | Details |
| A00226 | 35176096 | PLoS One | Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2022 | Details |
| A00276 | 35154609 | Gastroenterol Hepatol Bed Bench | Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran. | 2021 | Details |
| A00322 | 35136128 | Sci Rep | Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol Cohort Study (AmolCS). | 2022 | Details |
| A00334 | 35131122 | Clin Investig Arterioscler | Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path! | 2022 | Details |
| A00344 | 35126846 | World J Hepatol | Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence. | 2022 | Details |
| A00364 | 35118444 | touchREV Endocrinol | Potential Role of Dexamphetamine in the Treatment of Non-alcoholic Fatty Liver Disease: Hopes and Pitfalls. | 2021 | Details |
| A00385 | 35107763 | Curr Atheroscler Rep | Childhood Hypertriglyceridemia: Is It Time for a New Approach? | 2022 | Details |
| A00446 | 35080048 | J Gastroenterol Hepatol | Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
| A00453 | 35076162 | Hepatol Commun | Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community-Based Sample of Mexican-Origin Adults. | 2022 | Details |
| A00480 | 35067116 | Ethn Health | Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S. | 2022 | Details |
| A00511 | 35057439 | Nutrients | Mediterranean Diet and Fatty Liver Risk in a Population of Overweight Older Italians: A Propensity Score-Matched Case-Cohort Study. | 2022 | Details |
| A00536 | 35052726 | Biomedicines | Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets. | 2021 | Details |
| A00543 | 35052573 | Antioxidants (Basel) | Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea Pig. | 2021 | Details |
| A00544 | 35052547 | Antioxidants (Basel) | Preventive Effects of β-Cryptoxanthin, a Potent Antioxidant and Provitamin A Carotenoid, on Lifestyle-Related Diseases-A Central Focus on Its Effects on Non-Alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A00548 | 35050189 | Metabolites | The Role of Fructose as a Cardiovascular Risk Factor: An Update. | 2022 | Details |
| A00602 | 35034553 | J Med Econ | Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease. | 2022 | Details |
| A00606 | 35032545 | Metabolism | The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials. | 2022 | Details |
| A00613 | 35028685 | Calcif Tissue Int | Fatty Liver Index and Skeletal Muscle Density. | 2022 | Details |
| A00663 | 35010976 | Nutrients | Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota. | 2021 | Details |
| A00667 | 35010923 | Nutrients | Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review. | 2021 | Details |
| A00682 | 35004947 | Hepatobiliary Surg Nutr | The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study. | 2021 | Details |
| A00697 | 34999330 | Clin Nutr | Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis. | 2021 | Details |
| A00708 | 34993571 | Diabetologia | Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. | 2022 | Details |
| A00747 | 34981313 | Dig Dis Sci | Bariatric Surgery in NAFLD. | 2022 | Details |
| A00759 | 34977520 | JHEP Rep | Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. | 2021 | Details |
| A00784 | 34966657 | J Clin Transl Hepatol | Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). | 2021 | Details |
| A00788 | 34966296 | Front Psychiatry | Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A00865 | 34944682 | Biomedicines | Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic. | 2021 | Details |
| A00866 | 34944668 | Biomedicines | The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease. | 2021 | Details |
| A00884 | 34942286 | J Hepatol | Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. | 2021 | Details |
| A00886 | 34941156 | Medicine (Baltimore) | Effectiveness and safety of Shugan Jianpi (SGJP) formula in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review and meta-analysis of randomized controlled trials. | 2021 | Details |
| A00925 | 34927450 | J Am Heart Assoc | Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort. | 2021 | Details |
| A00934 | 34924365 | J Obes Metab Syndr | Severe Obesity in Children and Adolescents: Metabolic Effects, Assessment, and Treatment. | 2021 | Details |
| A00935 | 34924319 | Dig Liver Dis | Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). | 2021 | Details |
| A00936 | 34924246 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). | 2021 | Details |
| A00944 | 34922811 | J Diabetes Complications | DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. | 2021 | Details |
| A00945 | 34922644 | Lancet Diabetes Endocrinol | Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia. | 2021 | Details |
| A00965 | 34917315 | Frontline Gastroenterol | Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A00966 | 34917312 | Frontline Gastroenterol | Direct access lifestyle training improves liver biochemistry and causes weight loss but uptake is suboptimal in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A00975 | 34914079 | Eat Weight Disord | Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). | 2021 | Details |
| A01004 | 34904966 | Am J Gastroenterol | Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study. | 2022 | Details |
| A01044 | 34890795 | Clin Gastroenterol Hepatol | 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. | 2021 | Details |
| A01055 | 34886772 | Curr Alzheimer Res | Metabolic Syndrome, Alzheimer's Disease, and Covid 19: A Possible Correlation. | 2021 | Details |
| A01063 | 34883157 | J Hepatol | Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A01075 | 34877270 | World J Clin Cases | Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids. | 2021 | Details |
| A01087 | 34872379 | Am J Mens Health | A Qualitative Analysis of Mexican-Origin Men's Knowledge and Cultural Attitudes Toward Non-Alcoholic Fatty Liver Disease and Interest in Risk Reduction. | 2022 | Details |
| A01090 | 34871812 | Clin Gastroenterol Hepatol | Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01097 | 34870138 | Metabol Open | Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A01140 | 34857244 | Clin Nutr ESPEN | High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus. | 2021 | Details |
| A01146 | 34855640 | Chin Med J (Engl) | Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma. | 2021 | Details |
| A01149 | 34854066 | Hormones (Athens) | Nonalcoholic fatty liver disease: lifestyle and quality of life. | 2021 | Details |
| A01164 | 34847883 | BMC Gastroenterol | Total polyunsaturated fatty acid intake and the risk of non-alcoholic fatty liver disease in Chinese Han adults: a secondary analysis based on a case-control study. | 2021 | Details |
| A01183 | 34836332 | Nutrients | Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01207 | 34829753 | Biomedicines | Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC. | 2021 | Details |
| A01210 | 34829394 | Diagnostics (Basel) | A Step Closer to the "Fourth 90": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV. | 2021 | Details |
| A01217 | 34826302 | Am J Case Rep | A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH). | 2021 | Details |
| A01225 | 34822586 | Toxins (Basel) | Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis. | 2021 | Details |
| A01236 | 34818372 | PLoS One | Subclinical steatohepatitis and advanced liver fibrosis in health examinees with nonalcoholic fatty liver disease (NAFLD) in 10 South Korean cities: A retrospective cross-sectional study. | 2021 | Details |
| A01258 | 34813249 | Arch Argent Pediatr | [Obesity-fatty liver: the role of the pediatrician]. | 2021 | Details |
| A01264 | 34809412 | Endocrinol Metab (Seoul) | The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008-2011). | 2021 | Details |
| A01274 | 34805582 | Transl Gastroenterol Hepatol | Narrative review of current and emerging pharmacological therapies for nonalcoholic steatohepatitis. | 2021 | Details |
| A01275 | 34805412 | J Diabetes Res | Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus. | 2021 | Details |
| A01286 | 34802660 | Clin Liver Dis | Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease. | 2021 | Details |
| A01314 | 34791370 | J Nutr | Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control Study. | 2022 | Details |
| A01346 | 34780030 | Hepatol Int | Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study. | 2021 | Details |
| A01366 | 34773939 | Clin Exp Pediatr | Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with NASH/NAFLD: a randomized clinical trial. | 2021 | Details |
| A01369 | 34773093 | Eur J Clin Nutr | Role of high-salt diet in non-alcoholic fatty liver disease: a mini-review of the evidence. | 2021 | Details |
| A01403 | 34758930 | Arch Pediatr | The role of nutrition in non-alcoholic fatty liver disease treatment in obese children. | 2021 | Details |
| A01430 | 34749893 | Nurs Clin North Am | Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01459 | 34740573 | Metabolism | Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease. | 2021 | Details |
| A01469 | 34736535 | Cell Biosci | Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation. | 2021 | Details |
| A01506 | 34718870 | J Gastroenterol | Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review. | 2021 | Details |
| A01511 | 34715296 | Free Radic Biol Med | Role of vitamin E in the treatment of non-alcoholic steatohepatitis. | 2021 | Details |
| A01513 | 34712528 | Cureus | An Emerging Facet of Diabetes Mellitus: The Nexus of Gastrointestinal Disorders. | 2021 | Details |
| A01540 | 34704339 | Trop Med Int Health | Hepatic steatosis is associated with anthropometry, cardio-metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans. | 2021 | Details |
| A01575 | 34688168 | Curr Opin Pharmacol | Non-alcoholic fatty liver disease: Current therapeutic options. | 2021 | Details |
| A01604 | 34681228 | Pharmaceuticals (Basel) | Lipid-Lowering Bioactivity of Microalga Nitzschia laevis Extract Containing Fucoxanthin in Murine Model and Carcinomic Hepatocytes. | 2021 | Details |
| A01605 | 34681219 | Pharmaceuticals (Basel) | Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach. | 2021 | Details |
| A01629 | 34676233 | Front Nutr | NAFLD and Physical Exercise: Ready, Steady, Go! | 2021 | Details |
| A01659 | 34664301 | J Gastroenterol Hepatol | Diet and gut microbiome in fatty liver and its associated liver cancer. | 2021 | Details |
| A01677 | 34658280 | Hisp Health Care Int | Perceived Barriers to Weight Loss among Hispanic Patients with Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01688 | 34653686 | Ann Hepatol | Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016. | 2021 | Details |
| A01694 | 34652089 | J Sports Med Phys Fitness | Changes in mitochondrial biogenesis and fatty liver indicators in rat following continuous and high intensity interval training. | 2021 | Details |
| A01770 | 34622555 | Diabetes Obes Metab | Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. | 2021 | Details |
| A01780 | 34620653 | BMJ Open | Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation. | 2021 | Details |
| A01805 | 34609086 | United European Gastroenterol J | Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease. | 2021 | Details |
| A01822 | 34604270 | Front Nutr | Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants. | 2021 | Details |
| A01840 | 34595203 | Front Nutr | Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2021 | Details |
| A01850 | 34590082 | Aust J Gen Pract | Updates in fatty liver disease: Pathophysiology, diagnosis and management. | 2021 | Details |